↓ Skip to main content

Dove Medical Press

Focus on treatment of lung carcinoid tumor

Overview of attention for article published in OncoTargets and therapy, October 2013
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
30 Dimensions

Readers on

mendeley
48 Mendeley
Title
Focus on treatment of lung carcinoid tumor
Published in
OncoTargets and therapy, October 2013
DOI 10.2147/ott.s32464
Pubmed ID
Authors

Elise Noel-Savina, Renaud Descourt

Abstract

Bronchial typical carcinoid tumors are neuroendocrine bronchopulmonary tumors with a low-grade malignancy, and an atypical carcinoid is an intermediate form of these tumors. There is a lack of knowledge on the optimal treatment for these tumors. The surgical treatment of choice consists of a lobectomy supplemented by dissection. The benefit of chemotherapy and radiotherapy is unclear. Targeted therapy could be used in this condition, but there is a lack of research recommending it.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 48 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
France 1 2%
Unknown 47 98%

Demographic breakdown

Readers by professional status Count As %
Other 7 15%
Researcher 7 15%
Professor > Associate Professor 5 10%
Student > Bachelor 4 8%
Student > Postgraduate 4 8%
Other 10 21%
Unknown 11 23%
Readers by discipline Count As %
Medicine and Dentistry 28 58%
Nursing and Health Professions 2 4%
Agricultural and Biological Sciences 2 4%
Biochemistry, Genetics and Molecular Biology 1 2%
Pharmacology, Toxicology and Pharmaceutical Science 1 2%
Other 0 0%
Unknown 14 29%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 November 2013.
All research outputs
#20,656,820
of 25,374,917 outputs
Outputs from OncoTargets and therapy
#1,597
of 3,016 outputs
Outputs of similar age
#166,055
of 219,852 outputs
Outputs of similar age from OncoTargets and therapy
#21
of 34 outputs
Altmetric has tracked 25,374,917 research outputs across all sources so far. This one is in the 10th percentile – i.e., 10% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,016 research outputs from this source. They receive a mean Attention Score of 2.9. This one is in the 31st percentile – i.e., 31% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 219,852 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 11th percentile – i.e., 11% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 34 others from the same source and published within six weeks on either side of this one. This one is in the 11th percentile – i.e., 11% of its contemporaries scored the same or lower than it.